Latest stock market news videos & Morning Bell

From the helm: Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

Bell Direct
November 8, 2022

In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.
 
Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:

  • (0:56) A brief overview of Starpharma
  • (2:31) Growing distribution network for Viraleze
  • (3:29) SPL’s exciting oncology portfolio and key partnerships with major companies
  • (4:56) How Viraleze works and the market opportunity going forward
  • (6:09) What’s coming up next for SPL

Note: This interview was filmed on 20 October 2022.

Market Update

Bell Direct
December 15, 2017

Weekly Wrap 15 December

Bell Direct
December 15, 2017

Weekly Wrap 8 December

Bell Direct
December 8, 2017

Weekly Wrap 1 December

Bell Direct
December 1, 2017

November review & Portfolio strategy

Bell Direct
November 27, 2017

Weekly Wrap 24 November

Bell Direct
November 24, 2017

Weekly wrap 17 November

Bell Direct
November 17, 2017

Exclusive Interview with Charlie Aitken

Bell Direct
November 17, 2017

XTB’s High Yield & Cash Plus portfolios

Bell Direct
November 15, 2017

Weekly Wrap 3 November

Bell Direct
November 3, 2017